首页 | 本学科首页   官方微博 | 高级检索  
检索        

逍遥散联合美沙拉嗪肠溶片治疗溃疡性结肠炎随机平行对照研究
引用本文:李鹏,;杨少军,;王培宏.逍遥散联合美沙拉嗪肠溶片治疗溃疡性结肠炎随机平行对照研究[J].实用中医内科杂志,2014(5):85-87.
作者姓名:李鹏  ;杨少军  ;王培宏
作者单位:[1]兰州市城关区东岗街道社区卫生服务中心,兰州730020; [2]甘肃中医学院附属医院脾胃科,兰州730020; [3]兰州市城关区健康教育所,兰州730030
摘    要:目的]观察逍遥散联合美沙拉嗪肠溶片治疗溃疡性结肠炎疗效。方法]使用随机平行对照方法,将80例门诊患者按随机数字表法分为两组。对照组40例美沙拉嗪肠溶片1g/次,5次/d。治疗组40例逍遥散(炙甘草7g,柴胡16g,枳壳14g,党参22g,木香16g),1剂/d,水煎200mL,早晚温服;西医治疗同对照组。连续治疗12d为1疗程。观测临床症状、结肠黏膜状态、C-反应蛋白(CRP)、不良反应。治疗1疗程,判定疗效。结果]治疗组痊愈22例,有效16例,无效2例,总有效率95.00%。对照组痊愈15例,有效12例,无效13例,总有效率67.50%。治疗组疗效优于对照组(P0.05)。两组CRP值均有改善(P0.01),治疗组优于对照组(P0.01)。结论]逍遥散联合美沙拉嗪肠溶片治疗溃疡性结肠炎疗效显著,值得推广。

关 键 词:溃疡性结肠炎  气滞血瘀  肝肾阴虚  逍遥散  美沙拉嗪肠溶片  C-反应蛋白(CRP)  临床疗效  中医药疗法  随机平行对照研究

Xiaoyaosan Joint Mesalazine Treatment of Ulcerative Colitis Enteric-coated Tablets Parallel Randomized Controlled Study
Institution:LI Peng, YANG Shaojun, WANG Peihong ( 1. Chengguan District of Lanzhou Donggang Street Community Health Center, Lanzhou 730020, China; 2. Affiliated Hospital of Gansu College Traditional Chinese Medicine Department of Stomach Branch, Lanzhou 730020, China; 3. Chengguan District of Lanzhou City Health Education, Lanzhou 730030, China )
Abstract: Objective ] Xiaoyaosan joint mesalazine treatment of ulcerative colitis enteric-coated tablets. Method ] Random parallel control method, 80 outpatients were randomly divided into two groups. A control group of 40 patients mesalazine enteric-coated tablets lg / day, 5 times / d. Treatment group of 40 patients Xiaoyaosan (Zhigancao 7g, Bupleurum 16g, Fructus 14g, Codonopsis 22g, woody 16g), 1 close/d, decoction 200mL, sooner or later, warm clothes;Western medicine with the control group. 12d is a continuous course of treatment. Observation of clinical symptoms, CRP value, adverse reactions. A course of treatment to determine efficacy. Results ] The treatment group cure 22 cases, 16 cases effective, 2 cases noneffective, the total efficiency of 95.00%. The control group cure 15 cases, 12 cases effective, 13 cases noneffective, the total efficiency of 67.50%. Treatment group than the control group ( P 〈0.05 ) . CRP values were improved in both groups ( P 〈0.05 ), the treatment group than the control group ( P 〈0.05 ) . Conclusion ] Xiaoyaosan mesalazine enteric-coated tablets combined treatment of ulcerative colitis significant effect, worthy of promotion.
Keywords:Ulcerative colitis  Stagnation  Liver and kidney  Xiaoyaosan  Mesalazine enteric-coated tablets  CRP  Clinical efficacy  Traditional Chinese medicine treatment  Randomized parallel group study
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号